| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.055 | 242 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 7 | 1.275 | 258 |
| Total Expenses - EUR | 765 | 850 | 864 | 891 | 953 | 1.057 | 896 | 1.029 | 2.354 | 1.280 |
| Gross Profit/Loss - EUR | -765 | -850 | -864 | -891 | -953 | -1.048 | -896 | -1.022 | -1.079 | -1.022 |
| Net Profit/Loss - EUR | -765 | -850 | -864 | -891 | -953 | -1.048 | -896 | -1.023 | -1.079 | -1.022 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Denvalex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 27.237 | 3.910 | 3.003 | 2.066 | 1.091 | 221 | 254 | 440 | 2.205 | 1.260 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 595 | 494 |
| Receivables | 81 | 92 | 106 | 121 | 125 | 99 | 102 | 105 | 347 | 157 |
| Cash | 27.156 | 3.818 | 2.897 | 1.945 | 966 | 122 | 152 | 335 | 1.264 | 609 |
| Shareholders Funds | 27.157 | 3.816 | 2.888 | 1.944 | 953 | -112 | -1.006 | -2.031 | -3.104 | -4.109 |
| Social Capital | 103 | 102 | 100 | 98 | 96 | 94 | 92 | 93 | 92 | 92 |
| Debts | 80 | 94 | 115 | 122 | 138 | 333 | 1.260 | 2.471 | 5.329 | 5.411 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1623 - 1623" | |||||||||
| CAEN Financial Year |
1623
|
|||||||||
Comments - Denvalex S.r.l.